BOC Sciences provides high-quality hyaluronic acid (HA) nanogel development and preparation services for global customers. With extensive experience in biopolymer modification and high-precision nanomaterial preparation technology, we are capable of meeting the full process requirements from basic research to commercial production. Our HA nanogels offer excellent biocompatibility, adjustable physicochemical properties, and precise drug-controlled release capabilities, making them widely used in drug delivery, tissue engineering, skincare, and other biomedical fields.
Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan found in human connective tissues, skin, and synovial fluid. Due to its excellent water retention, biocompatibility, and biodegradability, it has broad applications in pharmaceuticals, cosmetics, and bioengineering. Nanogels are nanoscale hydrogels constructed from polymer networks, featuring a large surface area, excellent controlled release properties, and good solubility, making them efficient drug delivery systems. HA-based micro-nanogels combine the bioactivity of HA with the smart-responsive features of nanogels, making them especially suitable for applications in skin repair, joint treatment, anti-aging, targeted drug delivery, and tissue regeneration in the biomedical field. The advantages of HA-based nanogels lie in their high biocompatibility and biodegradability, allowing for long-term use in the body with safe metabolic products. Their outstanding water retention and lubrication properties enhance effectiveness in skincare and tissue engineering. Additionally, HA-based nanogels can efficiently load proteins, peptides, small molecule drugs, and gene therapy drugs, achieving precise therapeutic effects by adjusting the release rate.
Supports the development of HA nanogels with different molecular weights, modification groups, and crosslinking methods.
Provides precise control over nanoparticle size, morphology, and surface functionalization.
Develops HA nanogels responsive to temperature, pH, redox conditions, and enzymatic degradation.
Optimizes the loading and release of drugs/biologically active substances for controlled delivery.
Meets global pharmaceutical and medical device industry quality standards.
Provides comprehensive characterization and quality testing services.
Covers material design, functionality optimization, process scaling, and regulatory filing support.
Supports multiple industries, including drug delivery, regenerative medicine, tissue engineering, and cosmetics.
To meet various application needs, BOC Sciences employs multiple innovative HA nanogel preparation technologies. Each technology has its unique advantages, enabling precise control over particle size distribution, gel stability, mechanical properties, and degradation rate, thus optimizing the functionality and application performance of HA nanogels. These technologies offer flexible options for research and production, especially suitable for highly controllable and personalized product requirements. Whether in biomedicine, cosmetics, or other fields, BOC Sciences' HA nanogel preparation technologies provide efficient and safe solutions for customers.
Enables uniform dispersion and controllable particle sizes in HA nanogels, ideal for drug carriers and biomedical applications.
Constructs stable HA nanogels through non-covalent interactions, suitable for biologically active substance carriers.
Uses nanoparticle templates for precise HA nanogel synthesis, ideal for designing custom nanostructures.
Controls flow rate and mixing of HA solutions in microchannels, ensuring uniform nanogel preparation for small-scale production.
Enhances the mechanical properties and degradation rate of HA nanogels, suitable for long-acting drug delivery systems.
Uses physical forces like shear and grinding to produce nanoscale HA particles, enabling large-scale production.
Atomizes HA solutions into droplets and evaporates solvent to form HA nanogels, offering efficient particle size control and production.
Promotes self-assembly of HA molecules using ultrasound vibrations, ideal for medium and small-scale production.
BOC Sciences has extensive experience in the development of HA nanogels, providing end-to-end development services from conceptual design to product optimization. We combine advanced chemical modification, bioengineering techniques, and nanomaterials science to customize HA nanogels that meet various application needs across drug delivery, biomedical materials, cosmetic carriers, and biosensing fields. Our development services include the following key steps:
Based on customer requirements, BOC Sciences optimizes the physicochemical properties of HA nanogels, such as particle size, surface charge, crosslinking density, solubility, degradation rate, and drug release behavior.
We modify HA through chemical reactions such as acylation, esterification, and thioetherification to improve its stability, drug loading capacity, and biocompatibility, making it suitable for complex in vivo environments.
We use advanced technologies such as physical crosslinking, chemical crosslinking, self-assembly, and microfluidics to optimize the preparation process of HA nanogels, ensuring uniformity in particle size and structural stability.
We offer comprehensive in vitro and in vivo testing, including particle size analysis, Zeta potential measurement, rheological studies, stability evaluation, cytotoxicity testing, cellular uptake experiments, and in vivo pharmacokinetic studies.
To enhance the targeted delivery capability of HA nanogels, we provide surface modification services, such as conjugating specific ligands (e.g., folic acid, antibodies, or peptides), PEG modification to enhance circulation stability, or modifying cationic molecules through electrostatic interactions to improve cellular uptake. In addition, we offer functionalization of stimulus-responsive nanogels, which can undergo reversible changes in response to specific environmental factors (such as pH, temperature, light, enzyme activity, or redox conditions), enabling controlled release of drugs or bioactive molecules.
pH-responsive nanogels
Temperature-responsive nanogels
Light-responsive nanogels
Enzyme-responsive nanogels
Redox-responsive nanogels
PEG-modified nanogels
Folic acid-modified nanogels
Antibody-modified nanogels
Peptide-modified nanogels
Amino acid-modified nanogels
Nanoparticle composite nanogels
Liposome composite nanogels
Polymer composite nanogels
Exosome composite nanogels
Growth factor composite nanogels
BOC Sciences' HA nanogels possess excellent drug encapsulation capacity, capable of loading and stably encapsulating various types of active ingredients, including small molecule drugs, biomacromolecules, proteins, peptides, nucleic acids (such as siRNA, mRNA), and other bioactive factors. With advanced nanotechnology and precise crosslinking regulation strategies, we can optimize the drug loading capacity, increase encapsulation rates, and improve the release kinetics and targeted delivery effects of nanogels based on the physicochemical properties and mechanisms of different drugs, thereby enhancing the bioavailability and therapeutic effects of the drugs.
BOC Sciences possesses advanced GMP production facilities, focusing on the large-scale production of HA nanogels to ensure that products meet international pharmaceutical and biotechnology industry standards. Our GMP production system strictly follows FDA, EMA, and ICH guidelines, covering the entire quality management process from raw material procurement, formulation optimization, process control, to final product release. We adopt aseptic processes and closed production environments to strictly control microbial contamination risks, ensuring the biological safety and reproducibility of the nanogels. Furthermore, our GMP production facility has flexible production capabilities, supporting clinical research through to large-scale commercial production, meeting the diverse needs of the pharmaceutical, biotechnology, and cosmetics industries, and providing customers with high-quality, traceable HA nanogel products to support the development and application of innovative global drug delivery systems.
BOC Sciences has established a stringent quality control system and advanced analytical platform throughout the production process of HA nanogels, ensuring that each batch meets the highest quality standards. Our quality control covers the entire lifecycle management from raw material incoming inspection, production process, to final product release, ensuring that each step undergoes strict monitoring and verification. We use multidimensional analytical techniques, including particle size distribution, surface potential, drug loading rate, release behavior, and stability tests, to ensure that the physicochemical properties of the nanogels meet design requirements.
HA-based micro/nanogels have extensive application potential in the biomedical field due to their excellent biocompatibility, tunability, and efficient drug loading capability. These nanogels can effectively deliver drugs, proteins, nucleic acids, and other bioactive molecules to targeted tissues, improving therapeutic efficacy and reducing side effects. Due to the affinity of HA with cell surface receptors, they are particularly suitable for targeted drug delivery, gene therapy, and regenerative medicine. The stimulus-responsive and controlled release properties of HA-based micro/nanogels play an important role in the following biomedical applications:
Nanogel is a nanoscale network structure composed of polymeric materials, typically ranging from 1 to 1000 nanometers in diameter. It exhibits high hydration and hydrophilicity, forming a stable three-dimensional network in aqueous solutions. Nanogels are widely used in drug delivery, gene transfer, tissue engineering, and other fields, capable of loading drugs or biomolecules for controlled release.
Nanogels offer several advantages. First, their nanoscale enables them to cross cell membranes and tissue barriers for targeted delivery. Second, their high hydration provides good biocompatibility in the body. Finally, nanogels can control drug release rates by adjusting their physicochemical properties (such as particle size, surface charge), offering excellent sustained release performance.
While both hydrogels and nanogels are composed of hydrated polymers, they differ in size and properties. Hydrogels are typically micron-scale three-dimensional networks, whereas nanogels are nanoscale (1-1000 nanometers). Due to their smaller size and larger surface area, nanogels can better penetrate biological barriers and provide more precise drug delivery and controlled release capabilities.